IRCT20100314003566N12Not yet recruitingPhase 3
Therapeutic results of stem cells isolated from hair follicles in baldness treatment
Trial Snapshot
- Phase
- Phase 3
- Status
- Not yet recruiting
- Enrollment
- 10
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 30 years to no limit (—)
- Sex
- Male
Inclusion Criteria
- •Baldness stage 3 to 5 according to Norwood-Hamilton classification
- •Consent to participate in the study
Exclusion Criteria
- •Immune system suppression
- •Use of medical treatments for baldness (such as finasteride, dutasteride, or antiandrogens) during the past 12 months
Investigators
Similar Trials
Recruiting
Phase 3
Mesenchymal stem cells derived from the placenta and its secretions in the treatment of graft versus host diseaseGraft-versus-host diseaseGraft versus host disease.D89.81IRCT20201108049311N7Tabriz University of Medical Sciences30
Recruiting
Phase 1
Cell Therapy in Women's HealthStress urinary incontinenceC12.777.934.852.249RBR-29x2prniversidade Federal de São Paulo
Active, not recruiting
Phase 1
Infusion of mesenchymal stem cells as treatment for steroid resistant grade II to IV acute GVHD or poor graft function: a multicenter phase II studyEUCTR2007-004310-14-BECHU-ULG120
Withdrawn
Phase 2
Infusion of mesenchymal stem cells as treatment for steroid resistant grade II to IV acute GVHD or poor graft function: a multicenter phase II studymesenchymale stamcellen bij acute GvHD of onvoldoende functionerende greffeacute GvHD1002432410018865rejectionNL-OMON31471Academisch Ziekenhuis Maastricht10
Recruiting
Phase 1
Cell therapy with use of mesenchymal stem cells in infertile women with Thin EndometriumIRCT20230222057500N1Tehran University of Medical Sciences10